SIA MG LabsActive
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 11 000 € (59% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2012–2025
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||
| Total current assets | 3051 | 5182 | 8661 | 9516 | 10 510 | 6680 | 8594 | 8865 | 9981 | 14 138 | 15 726 | 21 274 | 21 846 | 18 160 |
| Total non-current assets | 656 | 219 | 0 | 0 | 0 | 0 | 145 | 1661 | 2922 | 1455 | 1247 | 1444 | 1159 | 19 137 |
| Total assets | 3707 | 5401 | 8661 | 9516 | 10 510 | 6680 | 8739 | 10 526 | 12 903 | 15 593 | 16 973 | 22 718 | 23 005 | 37 297 |
| Balance sheet — liabilities and equity | ||||||||||||||
| Current liabilities | 1426 | 1573 | 2583 | 1916 | 2149 | 2659 | 2656 | 2870 | 2876 | 5055 | 6909 | 4942 | 4481 | 7118 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 067 |
| Total liabilities | 1426 | 1573 | 2583 | 1916 | 2149 | 2659 | 2656 | 2870 | 2876 | 5055 | 6909 | 4942 | 4481 | 17 185 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 281 | 1547 | 631 | 1522 | 2262 | 1176 | 2062 | 1573 | 2371 | 511 | 4527 | 14 931 | 14 248 | 12 588 |
| Total equity | 2281 | 3828 | 6078 | 7600 | 8361 | 4021 | 6083 | 7656 | 10 027 | 10 538 | 10 064 | 17 776 | 18 524 | 20 112 |
| Income statement | ||||||||||||||
| Sales revenue | 7884 | 17 529 | 33 430 | 23 691 | 22 614 | 22 672 | 25 011 | 25 760 | 26 169 | 38 539 | 65 711 | 77 220 | 77 295 | 79 383 |
| Operating profit | 1060 | 3125 | 3640 | 3654 | 2262 | 1176 | 2062 | 1573 | 2371 | 511 | 4527 | 14 931 | 14 248 | 12 765 |
| Profit before income tax | 1060 | 3125 | 3640 | 3654 | 2262 | 1176 | 2062 | 1573 | 2371 | 511 | 4527 | 14 931 | 14 248 | 12 588 |
| Profit for the reporting year | 281 | 1547 | 631 | 1522 | 2262 | 1176 | 2062 | 1573 | 2371 | 511 | 4527 | 14 931 | 14 248 | 12 588 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Calculated dividend | — | 0 | 0 | 0 | 1501 | 5516 | 0 | 0 | 0 | 0 | 5001 | 7219 | 13 500 | 11 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Related companies
Summary: SIA MG Labs
Overview
SIA MG Labs (reg. no. 40103557924) is a limited liability company. The company was registered in 2012 and has been in the register for 14 years. Registered address: Rīga, Lēpju iela 9 - 68.
Financial results
Revenue in 2025 was 79 383 €, up 2,7% on the previous year (77 295 €). From 2012 to 2025, revenue grew by an average of 19,4% per year. This is the company's highest revenue among the published years (2012–2025). Net profit for 2025 was 12 588 € (15,9% of revenue). The company was profitable in all 14 published years. In 2025 the company had 1 employees. Revenue per employee was 79 383 €. At the end of 2025, total assets were 37 297 € and equity 20 112 € (53,9% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.